In LC cells, ADAMTS18 overexpression decreased EGFR/AKT activation[29], while secreted ADAMTS8 was found to reduce EGFR/MAPK/ERK signalling in oesophageal cancer cells[22]. This evidence concerns the gene ADAMTS8 and laryngotracheoesophageal cleft.